CD45.2+ lymphoma cells were negative for all evaluated B‐cell markers, including CD19, CD20, and Pax5, and instead expressed T‐cell markers CD3, Thy1, and TCRβ (Fig 2A and Appendix Fig S2C). This evidence concerns the gene CD19 and lymphoma.